Similarly, sialylation of the T antigen in MUC1 on breast cancer cells creates the MUC1–ST antigen which engages Singlec-9 on tumor-associated macrophages to initiate inhibitory immune signaling through the activation of the MAPK/ERK pathway (278). This evidence concerns the gene MUC1 and neoplasm.